Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1γ. (Q33814323)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1γ. |
scientific article |
Statements
1 reference
Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1γ. (English)
1 reference
David F Fiorentino
1 reference
Lorinda S Chung
1 reference
Lisa Christopher-Stine
1 reference
Lisa Zaba
1 reference
Shufeng Li
1 reference
Andrew L Mammen
1 reference
Antony Rosen
1 reference
Livia Casciola-Rosen
1 reference
1 November 2013
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference